Cargando…
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces antibodies that prevent establishment of a productive infection in mosquitos that feed on infec...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148045/ https://www.ncbi.nlm.nih.gov/pubmed/30237518 http://dx.doi.org/10.1038/s41467-018-06340-9 |
_version_ | 1783356686738653184 |
---|---|
author | Lennartz, Frank Brod, Florian Dabbs, Rebecca Miura, Kazutoyo Mekhaiel, David Marini, Arianna Jore, Matthijs M. Søgaard, Max M. Jørgensen, Thomas de Jongh, Willem A. Sauerwein, Robert W. Long, Carole A. Biswas, Sumi Higgins, Matthew K. |
author_facet | Lennartz, Frank Brod, Florian Dabbs, Rebecca Miura, Kazutoyo Mekhaiel, David Marini, Arianna Jore, Matthijs M. Søgaard, Max M. Jørgensen, Thomas de Jongh, Willem A. Sauerwein, Robert W. Long, Carole A. Biswas, Sumi Higgins, Matthew K. |
author_sort | Lennartz, Frank |
collection | PubMed |
description | The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces antibodies that prevent establishment of a productive infection in mosquitos that feed on infected humans, thereby stopping the transmission cycle. One of the most promising targets for such a vaccine is the gamete surface protein, Pfs48/45. Here we establish a system for production of full-length Pfs48/45 and use this to raise a panel of monoclonal antibodies. We map the binding regions of these antibodies on Pfs48/45 and correlate the location of their epitopes with their transmission-blocking activity. Finally, we present the structure of the C-terminal domain of Pfs48/45 bound to the most potent transmission-blocking antibody, and provide key molecular information for future structure-guided immunogen design. |
format | Online Article Text |
id | pubmed-6148045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61480452018-09-25 Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody Lennartz, Frank Brod, Florian Dabbs, Rebecca Miura, Kazutoyo Mekhaiel, David Marini, Arianna Jore, Matthijs M. Søgaard, Max M. Jørgensen, Thomas de Jongh, Willem A. Sauerwein, Robert W. Long, Carole A. Biswas, Sumi Higgins, Matthew K. Nat Commun Article The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces antibodies that prevent establishment of a productive infection in mosquitos that feed on infected humans, thereby stopping the transmission cycle. One of the most promising targets for such a vaccine is the gamete surface protein, Pfs48/45. Here we establish a system for production of full-length Pfs48/45 and use this to raise a panel of monoclonal antibodies. We map the binding regions of these antibodies on Pfs48/45 and correlate the location of their epitopes with their transmission-blocking activity. Finally, we present the structure of the C-terminal domain of Pfs48/45 bound to the most potent transmission-blocking antibody, and provide key molecular information for future structure-guided immunogen design. Nature Publishing Group UK 2018-09-20 /pmc/articles/PMC6148045/ /pubmed/30237518 http://dx.doi.org/10.1038/s41467-018-06340-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lennartz, Frank Brod, Florian Dabbs, Rebecca Miura, Kazutoyo Mekhaiel, David Marini, Arianna Jore, Matthijs M. Søgaard, Max M. Jørgensen, Thomas de Jongh, Willem A. Sauerwein, Robert W. Long, Carole A. Biswas, Sumi Higgins, Matthew K. Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
title | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
title_full | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
title_fullStr | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
title_full_unstemmed | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
title_short | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
title_sort | structural basis for recognition of the malaria vaccine candidate pfs48/45 by a transmission blocking antibody |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148045/ https://www.ncbi.nlm.nih.gov/pubmed/30237518 http://dx.doi.org/10.1038/s41467-018-06340-9 |
work_keys_str_mv | AT lennartzfrank structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT brodflorian structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT dabbsrebecca structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT miurakazutoyo structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT mekhaieldavid structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT mariniarianna structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT jorematthijsm structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT søgaardmaxm structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT jørgensenthomas structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT dejonghwillema structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT sauerweinrobertw structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT longcarolea structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT biswassumi structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody AT higginsmatthewk structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody |